Search

Search Constraints

You searched for: Author/Creator de Fijter, Johan W.

Search Results

1. 246.9: High Alemtuzumab Exposure Is Associated With Delayed Lymphocyte Recovery in Kidney Transplant Recipients. (13th September 2022)

2. 311.1: Real-Life Tacrolimus Levels Are Associated With Biopsyproven Acute Rejection After the First Year Post-kidney Transplantation. (13th September 2022)

3. 311.2: Early Tacrolimus Exposure Is Associated With BK-Viremia in Kidney Transplant Recipients. (13th September 2022)

4. 315.11: Tacrolimus Withdrawal After Mesenchymal Stromal Cell Therapy Is Associated With Donor-Specific Antibody Formation in Kidney Transplant Recipients. (13th September 2022)

5. Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury. Issue 7 (July 2017)

6. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients. Issue 10 (1st July 2019)

7. Autologous bone marrow‐derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study. Issue 9 (18th March 2021)

8. Autologous Bone Marrow‐Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study. (24th January 2013)